Clin Exp Reprod Med.  2017 Dec;44(4):175-180. 10.5653/cerm.2017.44.4.175.

Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines

Affiliations
  • 1Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea.
  • 2Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 3Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. kjhwang74@daum.net
  • 4Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Fertility preservation plays a central role in cancer care since an increasingly large number of cancer patients are surviving as a result of improvements in diagnostic and therapeutic strategies. Physicians who take part in the initial diagnosis and management of gynecologic cancer should understand the importance of fertility preservation. Since indications for fertility preservation are limited to early-stage gynecologic cancer, a surgeon must carefully consider each indication. Before performing fertility-sparing surgery, health professionals should compare its oncologic and pregnancy outcomes with those of other standard treatments. Individualized treatment strategies should be delivered depending on the patient's situation, and physicians should provide timely information and appropriate counseling.

Keyword

Fertility preservation; Fertility-sparing surgery; Gynecologic cancer; Pregnancy

MeSH Terms

Counseling
Diagnosis
Female
Fertility Preservation*
Fertility*
Health Occupations
Humans
Pregnancy
Pregnancy Outcome
Full Text Links
  • CERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error